Biomedical Opportunities Seen As Rare Bright Spot On Chemistry Job Horizon

Chemistry Job Horizon Author: MARCIA CLEMMITT, p.1 Especially for inorganic chemists, the employment picture for the discipline is said to be the grimmest it has been in decades A recent survey reveals that chemists currently face one of the worst job markets in the past 20 years in their discipline. Yet many of them believe that their field's growing importance to other research areas, especially biomedicine, will put chemists in a better position than many other science professionals

Written byMarcia Clemmitt
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Chemistry Job Horizon Author: MARCIA CLEMMITT, p.1

Especially for inorganic chemists, the employment picture for the discipline is said to be the grimmest it has been in decades

A recent survey reveals that chemists currently face one of the worst job markets in the past 20 years in their discipline. Yet many of them believe that their field's growing importance to other research areas, especially biomedicine, will put chemists in a better position than many other science professionals to benefit from any future economic upturn.

"The Ph.D.'s we produce are getting jobs, in part because the pharmaceutical industry has remained healthy," says Craig Hill, a professor of chemistry at Emory University in Atlanta. Emory's chemistry program is largely oriented toward biology and medicine, Hill says, and he attributes much ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies